The researchers found that most measures of social-emotional functioning showed impairment in women with AN or a history of AN, versus those with no eating disorder history.
Mediation analyses using bootstrapping procedures indicated that all paths were significant and that leptin mediated the link between WS and illness duration.
Percent median body mass index improved significantly from baseline to the end of treatment (P=0.013) and from baseline to the 6-month follow-up (P=0.032).
Syndros is the first FDA-approved dronabinol solution for oral administration, containing the pharmaceutical version of tetrahydrocannabinol (THC).
Adolescents who met criteria for anorexia nervosa or bulimia nervosa were 2.4 and 1.9 times, respectively, more likely to seek treatment than adolescents who met criteria for binge-eating disorder.
For select patients, psychostimulants may be beneficial for treating bulimia nervosa, according to a study of six cases published online January 23 in the Journal of Clinical Pharmacology.
Seventeen percent of high school students say they have engaged in non-medical use of prescription drugs (NMUPD), according to a recent Youth Risk Behavior Survey.
The FDA has approved Syndros (dronabinol oral solution) for the treatment of anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
Women with eating disorders more often exhibit risky drinking behaviors than their unaffected peers, according to a study published online April 1 in the International Journal of Eating Disorders.
Mortality is increased among patients with eating disorders, with higher mortality for those with anorexia nervosa (AN) compared with bulimia nervosa (BN), binge eating disorder (BED), and eating disorder not otherwise specified (ED-NOS), according to a study published online in the International Journal of Eating Disorders.
For adults with severe anorexia nervosa (AN), elevated liver enzymes are relatively common and are associated with lower body mass index (BMI) and hypoglycemia.
Recent research has shown that an increasing number of men are using over-the-counter bodybuilding supplements to the point where it may be characterized as an eating disorder.
Par Pharmaceuticals announced the launch of Megestrol Acetate Suspension, the generic version of its brand Megace ES.
TWi Pharmaceuticals announced the launch of Megestrol Acetate Suspension, the generic version of Par Pharmaceutical's Megace ES.
The clinical features of citrin deficiency (CD) may mimic those of anorexia nervosa (AN), according to a case report published in Pediatrics.
The American Geriatrics Society (AGS) has released updates to its recommendations for the ABIM Foundation's Choosing Wisely campaign to reflect new research on conditions affecting older adults, such as agitation, certain types of cancer, delirium, dementia, and others.
Eating disorder education needs to reach overweight youth, as the prevalence of disordered eating among overweight girls and boys remained the same from 1999 to 2010.
In patients with anorexia nervosa, plasma levels of vitamin B12 might be an early marker of liver dysfunction and are possibly related to more severe psychopathological aspects.
Refeeding patients with anorexia nervosa to achieve more rapid weight gain may be safe and effective in a hospital-based protocol.
A grading system has been developed for clinically important weight loss (WL) in patients with cancer, which includes the independent prognostic significance of body mass index (BMI) and percent WL.
The condition orthorexia nervosa is not officially recognized in the DSM-V, yet doctors and registered dieticians are seeing an increase in patients with symptoms of the disorder along with a preoccupation with healthy eating.
TWi Pharmaceuticals announced that it has received final approval for Megestrol Acetate Suspension, the generic version of Par Pharmaceutical's Megace ES.